{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/candida-female-genital/how-up-to-date-is-this-topic/update/","result":{"pageContext":{"chapter":{"id":"3fde567e-3066-57d8-be3e-016c389f8b94","slug":"update","fullItemName":"Update","depth":2,"htmlHeader":"<!-- begin field e840a3b4-e32a-4557-a8dd-982a79bb2de2 --><h2>Update</h2><!-- end field e840a3b4-e32a-4557-a8dd-982a79bb2de2 -->","summary":null,"htmlStringContent":"<!-- begin item d6e285e1-6275-424c-b2a7-6c56c1bfbb8e --><!-- end item d6e285e1-6275-424c-b2a7-6c56c1bfbb8e -->","topic":{"id":"99e20f18-68df-560d-b5d3-b6ec31ccad61","topicId":"1a8f74c5-56a3-4356-a328-97bd2f790f35","topicName":"Candida - female genital","slug":"candida-female-genital","lastRevised":"Last revised in MayÂ 2017","chapters":[{"id":"de1ba63a-d3be-5e38-9afa-2decfb6a4104","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"70e5dc95-dca6-5aed-ba02-7677e5595791","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"7785eebb-7adf-5829-8438-054465d94780","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"17acaa38-dc82-5062-9b9e-b70e43844f09","slug":"changes","fullItemName":"Changes"},{"id":"3fde567e-3066-57d8-be3e-016c389f8b94","slug":"update","fullItemName":"Update"}]},{"id":"7bdd785b-dd70-5bde-a56b-ece7a71c1890","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"2aea51d9-2817-5901-8b3f-003e41a1f1b9","slug":"goals","fullItemName":"Goals"},{"id":"16c71775-c8a9-58f1-b6e8-00d83ea3e32a","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"584f77ef-93e6-5c84-93b4-8331fed80193","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"ffb6e4fa-b86a-5191-9bbb-c113c86952b6","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"cc13b04c-c8b4-5403-a61e-10f784bc17de","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"8ba1a16f-d8bd-55bc-8208-17beaddd9264","slug":"nice-quality-standards","fullItemName":"NICE Quality standards"}]},{"id":"d90c278f-fcf0-5c7c-aeab-b0decc2194dd","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"5d851a40-f1f9-50de-b7de-3e374a862b45","slug":"definition","fullItemName":"Definition"},{"id":"51060b0d-4f1d-5133-9645-6efc6b9ca9d8","slug":"prevalence","fullItemName":"Prevalence"},{"id":"c7dd35c5-dc87-55a0-b15e-5fd3c5f79ede","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"bcbc381a-db1c-5df4-a8fa-cb1ce02a4ab3","slug":"complications","fullItemName":"Complications"},{"id":"2ec519a6-61da-53cb-b5c6-e53420e1f175","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"1296609f-72a1-5634-918b-eb0f9bf2b217","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"197fc582-d823-5341-813b-4d48a895ac84","slug":"assessment","fullItemName":"Assessment"},{"id":"7fa609e6-64b1-5e1e-a2fe-9d8aaae57662","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"b7ed2787-e953-5da0-ba29-6ad5d5aa7138","fullItemName":"Management","slug":"management","subChapters":[{"id":"0d8e43cc-e312-572a-97eb-50ab1223bf29","slug":"uncomplicated-infection","fullItemName":"Scenario: Uncomplicated infection"},{"id":"20ef6f32-4f35-577b-af2b-0479dafd7a6f","slug":"severe-infection","fullItemName":"Scenario: Severe infection"},{"id":"19018671-1df6-546c-a24e-c0277342e2e1","slug":"recurrent-infection","fullItemName":"Scenario: Recurrent infection"},{"id":"0f525c4d-623c-5b02-9045-c7f9c57692e4","slug":"diabetes-or-immunocompromised","fullItemName":"Scenario: Diabetes or immunocompromised"},{"id":"d143d272-2856-5fad-95fe-708b221847f0","slug":"during-pregnancy","fullItemName":"Scenario: During pregnancy"}]},{"id":"fa8e2e27-5ea4-5088-86f8-65ffd101ec26","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"a11071ae-b868-56f6-a390-4809b91594ea","slug":"choice-of-antifungals","fullItemName":"Choice of antifungals"},{"id":"169ff7be-fabd-556e-bdf3-92c30e390f3d","slug":"intravaginal-antifungals","fullItemName":"Intravaginal antifungals"},{"id":"cca352b0-a363-5b43-97d2-9df0dbf242b6","slug":"oral-fluconazole","fullItemName":"Oral fluconazole"},{"id":"754e0483-3f11-5510-9b98-7f8c44679e56","slug":"oral-itraconazole","fullItemName":"Oral itraconazole"},{"id":"2ae3a41b-64fa-5372-baba-bb8c04e033d8","slug":"topical-antifungals","fullItemName":"Topical antifungals"}]},{"id":"dd75ee8e-5efd-51c0-bcc2-3af7ee1253e7","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"74d9d85c-590f-5e29-a202-78d94a6f747f","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"d7a69713-bc5d-57da-9132-ff07c7fef62c","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"a8d93477-c70c-5177-92d7-e96545a6b2f7","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"4841d69e-1e2b-5aec-9c3b-1ea8cd8bbf08","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"b3113b9f-1b0e-5987-99b4-e616eb6d128a","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"0e41c5da-d9a8-5c0d-bb7f-f68cda4acb05","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"6eb1b4a4-5ae4-5a59-8ca6-6434652b9454","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"7785eebb-7adf-5829-8438-054465d94780","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?"},"subChapters":[{"id":"157ef088-7ed3-5e91-8075-78bdc3e2894a","slug":"new-evidence","fullItemName":"New evidence","depth":3,"htmlHeader":"<!-- begin field ff0917e6-4dfb-4626-a744-d8224b210dcc --><h3>New evidence</h3><!-- end field ff0917e6-4dfb-4626-a744-d8224b210dcc -->","summary":null,"htmlStringContent":"<!-- begin item 9134783b-8447-4c6a-a955-1b988c0f1170 --><!-- begin field e7812a01-6e37-48d6-a8c3-fa5359bc35f9 --><h3>Evidence-based guidelines</h3><!-- end field e7812a01-6e37-48d6-a8c3-fa5359bc35f9 --><!-- begin field 254c3ebb-8706-49ba-b03a-8efd53bb9682 --><p>No new evidence-based guidelines since 1 October 2016.</p><!-- end field 254c3ebb-8706-49ba-b03a-8efd53bb9682 --><!-- begin field fed0430d-87bc-4c89-b09a-000e2e111291 --><h3>HTAs (Health Technology Assessments)</h3><!-- end field fed0430d-87bc-4c89-b09a-000e2e111291 --><!-- begin field baa06527-5df2-4276-a3ec-ba3f180d39e7 --><p>No new HTAs since 1 October 2016.</p><!-- end field baa06527-5df2-4276-a3ec-ba3f180d39e7 --><!-- begin field 2e7267d6-feab-4864-b4c9-bf18f2131207 --><h3>Economic appraisals</h3><!-- end field 2e7267d6-feab-4864-b4c9-bf18f2131207 --><!-- begin field 10a67a9d-758c-470f-937f-d093de19c2f3 --><p>No new economic appraisals relevant to England since 1 October 2016.</p><!-- end field 10a67a9d-758c-470f-937f-d093de19c2f3 --><!-- begin field 089e2949-7c5a-4db9-ad8d-8ddf05297c25 --><h3>Systematic reviews and meta-analyses</h3><!-- end field 089e2949-7c5a-4db9-ad8d-8ddf05297c25 --><!-- begin field c511a1cc-f6ca-41eb-9940-1e3891e8b5de --><ul><li>Denison, H.J., Worswick, J., Bond, C.M., et al. (2020) <em>Oral versus intra-vaginal imidazole and triazole anti-fungal treatment of uncomplicated vulvovaginal candidiasis (thrush).</em> Cochrane Library. <a href=\"https://www.cochranelibrary.com/\" data-hyperlink-id=\"4e18a0c6-5de4-4539-8b4f-ac4f00ab5348\">www.cochranelibrary.com</a> [<a href=\"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD002845.pub3/full\" data-hyperlink-id=\"ddb552c5-dc2b-4e00-9e52-ac4f00ab5421\">Free Full-text</a>]</li></ul><!-- end field c511a1cc-f6ca-41eb-9940-1e3891e8b5de --><!-- begin field 0f4ce89f-6c81-4282-9320-7c7ba5521f45 --><h3>Primary evidence</h3><!-- end field 0f4ce89f-6c81-4282-9320-7c7ba5521f45 --><!-- begin field 59fe0614-016f-4d58-aff4-2c7608ebb1bf --><p>No new randomized controlled trials published in the major journals since 1 October 2016.</p><!-- end field 59fe0614-016f-4d58-aff4-2c7608ebb1bf --><!-- end item 9134783b-8447-4c6a-a955-1b988c0f1170 -->","subChapters":[]},{"id":"283bb273-6816-53cc-b306-88e44ad20251","slug":"new-policies","fullItemName":"New policies","depth":3,"htmlHeader":"<!-- begin field cfa7d9d9-576e-4390-9d4e-8e2d36eb59c7 --><h3>New policies</h3><!-- end field cfa7d9d9-576e-4390-9d4e-8e2d36eb59c7 -->","summary":null,"htmlStringContent":"<!-- begin item 25780ef6-46bb-4304-a981-7b374b3cd3ec --><!-- begin field 81c7d755-fb79-499b-b96a-19383f7c0239 --><p>No new national policies or guidelines since 1 October 2016.</p><!-- end field 81c7d755-fb79-499b-b96a-19383f7c0239 --><!-- end item 25780ef6-46bb-4304-a981-7b374b3cd3ec -->","subChapters":[]},{"id":"68244de4-3fd1-5522-8a3c-d1dacd8399b9","slug":"new-safety-alerts","fullItemName":"New safety alerts","depth":3,"htmlHeader":"<!-- begin field 8b87583d-e691-416d-8411-dde5ff266224 --><h3>New safety alerts</h3><!-- end field 8b87583d-e691-416d-8411-dde5ff266224 -->","summary":null,"htmlStringContent":"<!-- begin item f4ad8fd0-4163-4af0-8d2c-394efcf1ec03 --><!-- begin field fbd55539-27b3-420d-aefe-b02ef8065b1f --><p>No new safety alerts since 1 October 2016.</p><!-- end field fbd55539-27b3-420d-aefe-b02ef8065b1f --><!-- end item f4ad8fd0-4163-4af0-8d2c-394efcf1ec03 -->","subChapters":[]},{"id":"8e93834e-b9b8-5a8c-830b-a0183b02d0ff","slug":"changes-in-product-availability","fullItemName":"Changes in product availability","depth":3,"htmlHeader":"<!-- begin field 8df02a40-7ed1-453a-96f0-e9e32dcfecc7 --><h3>Changes in product availability</h3><!-- end field 8df02a40-7ed1-453a-96f0-e9e32dcfecc7 -->","summary":null,"htmlStringContent":"<!-- begin item 2659413c-cc9b-4955-826e-05292492ba0d --><!-- begin field f8620936-e73b-4195-8fbe-b7d6e5dc93c4 --><p>No changes in product availability since 1 October 2016.</p><!-- end field f8620936-e73b-4195-8fbe-b7d6e5dc93c4 --><!-- end item 2659413c-cc9b-4955-826e-05292492ba0d -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}